Pertussis vaccine: Difference between revisions

From WikiMD's Medical Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
Line 34: Line 34:
[[Category:Medical treatments]]
[[Category:Medical treatments]]
[[Category:Immunology]]
[[Category:Immunology]]
<gallery>
File:DPT-IPV-japan_Quattro_back.jpg|DPT-IPV Japan Quattro vaccine packaging
File:Pertussis_notifications.png|Pertussis notifications graph
</gallery>

Latest revision as of 01:00, 18 February 2025

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.

Types[edit]

There are two main types of pertussis vaccines: whole-cell vaccines (wP) and acellular vaccines (aP).

Whole-cell vaccines[edit]

Whole-cell vaccines are made from the entire Bordetella pertussis bacterium. They have been in use since the 1940s and are about 78% effective.

Acellular vaccines[edit]

Acellular vaccines, which are made from a part of the Bordetella pertussis bacterium, have been in use since the 1980s. They are about 71–85% effective.

Usage[edit]

The pertussis vaccine is given by injection into a muscle. It is often given in combination with diphtheria and tetanus vaccines.

Side effects[edit]

Common side effects include redness, swelling at the site of the injection, fever, and crying. Serious side effects are rare.

History[edit]

The first pertussis vaccine was developed in the 1930s and was in widespread use by the 1940s. The acellular vaccine was developed in the 1980s in response to concerns about side effects from the whole-cell vaccine.

See also[edit]

References[edit]

<references />

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia